Left ventricular (LV) dysfunction c-kit-positive, lineage-negative cardiac stem cells (CSC) improving post-infarction when given to animals. We conducted an experiment phase 1 (Stem Cell Infusion in Patients with ischemic cardiomyopathy [Scipio]) from autologous CSC for the treatment of heart failure due to ischemic heart disease.In trial stage A Scipio, patients with post-infarction LV dysfunction (ejection fraction [EF] ≤ 40%) prior to coronary artery bypass grafting were consecutively enrolled in the treatment and control groups. In stage B, patients were randomly assigned to treatment or control groups in a ratio of 2: 3 by using the block scheme of computer-generated randomization. 1 million autologous CSC given by intracoronary infusion at an average of 113 days (SE 4) after surgery; untreated controls.
Although this study is an open label, echocardiographic analysis did not know the duties of the group. The primary endpoint was a short-term security of CSC and the secondary endpoint was efficacy. A per-protocol analysis were used. This study is registered with ClinicalTrials.gov, number NCT00474461.This study is still in progress. 16 patients were assigned to the treatment group and seven for the control group; no side effects were reported related CSC.
On 14 CSC-treated patients were analyzed, LVEF increased from 30 · 3% (SE 1 · 9) before CSC infusion to 38 · 5% (2 · 8) at 4 months after infusion (p = 0 · 001). In contrast, the seven control patients, as long as the appropriate time interval, LVEF did not change (30 · 1% [2 · 4] at 4 months after CABG vs 30 · 2% [2 · 5] at 8 months after CABG). Importantly, CSC healthful effects are even more pronounced in the first year in eight patients (eg, LVEF increased by 12 · 3 unit ejection fraction [2 · 1] vs baseline, p = 0 · 0007).
In seven patients treated in whom cardiac MRI can be done, infarct size decreased from 32 · 6 g (6 · 3) by 7 · 8 g (1 · 7; 24%) at 4 months (p = 0 · 004) and 9 · 8 g (3 · 5; 30%) at 1 year (p = 0 · 04) .This preliminary results in patients with very encouraging. They suggest that intracoronary infusion of autologous CSC effective in improving LV systolic function and reduced infarct size in patients with heart failure after myocardial infarction, and warrant further, larger, phase 2 studies.University of Louisville Research Foundation and the National Institutes of Health ,
D-Luciferin sodium salt |
B8311-50 |
ApexBio |
50 mg |
EUR 293 |
D-Luciferin, Sodium Salt |
7902-100 |
Biovision |
|
EUR 120 |
D-Luciferin, Sodium Salt |
7902-10G |
Biovision |
|
EUR 2409 |
D-Luciferin, Sodium Salt |
7902-10PK |
Biovision |
|
EUR 2763 |
D-Luciferin, Sodium Salt |
7902-1G |
Biovision |
|
EUR 354 |
D-Luciferin, Sodium Salt |
7902-25G |
Biovision |
|
Ask for price |
D-Luciferin, Sodium Salt |
7902-3PK |
Biovision |
|
EUR 925 |
D-Luciferin, Sodium Salt |
7902-50G |
Biovision |
|
Ask for price |
D-Luciferin, Sodium Salt |
7902-5PK |
Biovision |
|
EUR 1496 |
D-Luciferin, sodium salt |
10102 |
Biotium |
10MG |
EUR 123 |
Description: Minimum order quantity: 1 unit of 10MG |
D-Luciferin, sodium salt |
10102-1 |
Biotium |
50MG |
EUR 245 |
Description: Minimum order quantity: 1 unit of 50MG |
D-Luciferin, sodium salt |
10102-2 |
Biotium |
1G |
EUR 714 |
Description: Minimum order quantity: 1 unit of 1G |
D-Luciferin, Potassium Salt |
7903-100 |
Biovision |
|
EUR 120 |
D-Luciferin, Potassium Salt |
7903-10G |
Biovision |
|
EUR 2409 |
D-Luciferin, Potassium Salt |
7903-10PK |
Biovision |
|
EUR 2763 |
D-Luciferin, Potassium Salt |
7903-1G |
Biovision |
|
EUR 354 |
D-Luciferin, Potassium Salt |
7903-25G |
Biovision |
|
Ask for price |
D-Luciferin, Potassium Salt |
7903-3PK |
Biovision |
|
EUR 925 |
D-Luciferin, Potassium Salt |
7903-50G |
Biovision |
|
Ask for price |
D-Luciferin, Potassium Salt |
7903-5PK |
Biovision |
|
EUR 1496 |
D-Luciferin, potassium salt |
10101 |
Biotium |
10MG |
EUR 112 |
Description: Minimum order quantity: 1 unit of 10MG |
D-Luciferin, potassium salt |
10101-1 |
Biotium |
50MG |
EUR 234 |
Description: Minimum order quantity: 1 unit of 50MG |
D-Luciferin, potassium salt |
10101-2 |
Biotium |
1G |
EUR 714 |
Description: Minimum order quantity: 1 unit of 1G |
D-Luciferin, Potassium Salt |
D0510-010 |
GenDepot |
100mg |
EUR 185 |
D-Luciferin, Potassium Salt |
D0510-050 |
GenDepot |
500mg |
EUR 504 |
D-Luciferin, Potassium Salt |
D0510-100 |
GenDepot |
1g |
EUR 847 |
D-Luciferin, sodium salt *CAS#: 103404-75-7* |
12509 |
AAT Bioquest |
25 mg |
EUR 115 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 41105331
|
D-Luciferin, sodium salt *CAS#: 103404-75-7* |
12510 |
AAT Bioquest |
100 mg |
EUR 132 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 41105331
|
D-Luciferin, sodium salt *CAS#: 103404-75-7* |
12511 |
AAT Bioquest |
1 g |
EUR 528 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 41105331
|
EZSolution? D-Luciferin, Potassium Salt |
B3001-set |
Biovision |
|
EUR 370 |
Brite-Light? D-Luciferin, Potassium Salt |
B3000-10PK |
Biovision |
|
EUR 2268 |
Brite-Light? D-Luciferin, Potassium Salt |
B3000-1G |
Biovision |
|
EUR 327 |
Brite-Light? D-Luciferin, Potassium Salt |
B3000-5PK |
Biovision |
|
EUR 1300 |
D-Luciferin |
B6040-10 |
ApexBio |
10 mg |
EUR 131 |
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP. |
D-Luciferin |
B6040-200 |
ApexBio |
200 mg |
EUR 699 |
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP. |
D-Luciferin |
B6040-50 |
ApexBio |
50 mg |
EUR 293 |
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP. |
D-Luciferin, potassium salt *CAS#: 115144-35-9* |
12505 |
AAT Bioquest |
25 mg |
EUR 115 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 41105331
|
D-Luciferin, potassium salt *CAS#: 115144-35-9* |
12506 |
AAT Bioquest |
100 mg |
EUR 132 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 41105331
|
D-Luciferin, potassium salt *CAS#: 115144-35-9* |
12507 |
AAT Bioquest |
1 g |
EUR 263 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 41105331
|
D-Luciferin acetate |
12516 |
AAT Bioquest |
5 mg |
EUR 219 |
- R-phrase: R20, R21, R22
- H-Phrase: H303, H313, H333
- Symbol for dangerous compounds: Xn
- UNSPEC Code: 41105331
|
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-10 |
ApexBio |
10 mg |
EUR 206 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-25 |
ApexBio |
25 mg |
EUR 338 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-5 |
ApexBio |
5 mg |
EUR 132 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-50 |
ApexBio |
50 mg |
EUR 502 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-1 |
ApexBio |
1 mg |
EUR 118 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-10 |
ApexBio |
10 mg |
EUR 527 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-25 |
ApexBio |
25 mg |
EUR 1073 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-5 |
ApexBio |
5 mg |
EUR 306 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
D-Glucuronic acid, sodium salt, monohydrate |
GB0483 |
Bio Basic |
5g |
EUR 107.42 |
- Product category: Biochemicals/Carbohydrates/Sugars
|
D-Luciferin, free acid |
10100 |
Biotium |
10MG |
EUR 112 |
Description: Minimum order quantity: 1 unit of 10MG |
D-Luciferin, free acid |
10100-1 |
Biotium |
50MG |
EUR 234 |
Description: Minimum order quantity: 1 unit of 50MG |
D-Luciferin, free acid |
10100-2 |
Biotium |
1G |
EUR 714 |
Description: Minimum order quantity: 1 unit of 1G |
D-Luciferin (Free acid) |
2779-1000 |
Biovision |
|
EUR 338 |
D-Luciferin (Free acid) |
2779-250 |
Biovision |
|
EUR 175 |
D-Luciferin (Free acid) |
2779-500 |
Biovision |
|
EUR 251 |
D-Luciferin (Free acid) |
2779-5000 |
Biovision |
|
EUR 1273 |
Ampicillin Sodium Salt |
AK0839-0010 |
Akron Biotech |
10g |
Ask for price |
Ampicillin Sodium Salt |
AK0839-0025 |
Akron Biotech |
25g |
Ask for price |
Ampicillin Sodium Salt |
AK0839-0100 |
Akron Biotech |
100g |
Ask for price |
Cefonicid (sodium salt) |
C3812-1000 |
ApexBio |
1 g |
EUR 406 |
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins. |
Cefonicid (sodium salt) |
C3812-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins. |
Cefonicid (sodium salt) |
C3812-500 |
ApexBio |
500 mg |
EUR 251 |
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins. |
Cefoperazone (sodium salt) |
C3913-10000 |
ApexBio |
10 g |
EUR 403 |
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1]. |
Cefoperazone (sodium salt) |
C3913-5000 |
ApexBio |
5 g |
EUR 267 |
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1]. |
Moxalactam (sodium salt) |
C4121-1000 |
ApexBio |
1 g |
EUR 225 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Moxalactam (sodium salt) |
C4121-250 |
ApexBio |
250 mg |
EUR 112 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Moxalactam (sodium salt) |
C4121-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Moxalactam (sodium salt) |
C4121-500 |
ApexBio |
500 mg |
EUR 168 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Cefazolin (sodium salt) |
C4183-1000 |
ApexBio |
1 g |
EUR 168 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Cefazolin (sodium salt) |
C4183-250 |
ApexBio |
250 mg |
EUR 105 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Cefazolin (sodium salt) |
C4183-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Cefazolin (sodium salt) |
C4183-500 |
ApexBio |
500 mg |
EUR 138 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Tazobactam (sodium salt) |
C4245-1000 |
ApexBio |
1 g |
EUR 226 |
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. |
Tazobactam (sodium salt) |
C4245-250 |
ApexBio |
250 mg |
EUR 116 |
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. |
Tazobactam (sodium salt) |
C4245-500 |
ApexBio |
500 mg |
EUR 168 |
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. |
Simvastatin (sodium salt) |
C4426-100 |
ApexBio |
100 mg |
EUR 392 |
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs. |
Simvastatin (sodium salt) |
C4426-25 |
ApexBio |
25 mg |
EUR 196 |
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs. |
Moniliformin (sodium salt) |
C4459-1 |
ApexBio |
1 mg |
EUR 321 |
Description: Moniliformin induces mitotic arrest at the metaphase stage.Mitosis is a part of the cell cycle when replicated chromosomes are separated into two new nuclei. |
Cefotaxime (sodium salt) |
C4588-1000 |
ApexBio |
1 g |
EUR 126 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Cefotaxime (sodium salt) |
C4588-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Cefotaxime (sodium salt) |
C4588-500 |
ApexBio |
500 mg |
EUR 108 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Cefotaxime (sodium salt) |
C4588-5000 |
ApexBio |
5 g |
EUR 151 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Lorglumide (sodium salt) |
C4809-25 |
ApexBio |
25 mg |
EUR 145 |
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] . |
Lorglumide (sodium salt) |
C4809-50 |
ApexBio |
50 mg |
EUR 171 |
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] . |
Cefoxitin (sodium salt) |
C4849-1000 |
ApexBio |
1 g |
EUR 241 |
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2]. |
Cefoxitin (sodium salt) |
C4849-250 |
ApexBio |
250 mg |
EUR 113 |
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2]. |
Cefoxitin (sodium salt) |
C4849-500 |
ApexBio |
500 mg |
EUR 164 |
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2]. |
Fosmidomycin (sodium salt) |
C4898-10 |
ApexBio |
10 mg |
EUR 415 |
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces. |
Fosmidomycin (sodium salt) |
C4898-25 |
ApexBio |
25 mg |
EUR 830 |
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces. |
Fosmidomycin (sodium salt) |
C4898-5 |
ApexBio |
5 mg |
EUR 244 |
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces. |
Cefsulodin (sodium salt) |
C5593-1000 |
ApexBio |
1 g |
EUR 224 |
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1]. |
Cefsulodin (sodium salt) |
C5593-250 |
ApexBio |
250 mg |
EUR 123 |
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1]. |
Cefsulodin (sodium salt) |
C5593-500 |
ApexBio |
500 mg |
EUR 180 |
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1]. |
Furegrelate (sodium salt) |
C5692-10 |
ApexBio |
10 mg |
EUR 170 |
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2. |
Furegrelate (sodium salt) |
C5692-5 |
ApexBio |
5 mg |
EUR 112 |
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2. |
Furegrelate (sodium salt) |
C5692-50 |
ApexBio |
50 mg |
EUR 551 |
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2. |
Cefoxitin Sodium Salt |
B1892-1G |
Biovision |
|
EUR 185 |
Cefoxitin Sodium Salt |
B1892-500 |
Biovision |
|
EUR 131 |
Cefoxitin Sodium Salt |
B1892-5G |
Biovision |
|
EUR 577 |
Azlocillin sodium salt |
B1893-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 108 |
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria. |
Azlocillin sodium salt |
B1893-50 |
ApexBio |
50 mg |
EUR 128 |
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria. |
Azlocillin sodium salt |
B1893-S |
ApexBio |
Evaluation Sample |
EUR 81 |
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria. |
Sulfamerazine sodium salt |
B3430-100000 |
ApexBio |
100 g |
EUR 137 |
Description: Sulfamerazine Sodium is a sulfonamide antibacterial. |
Sulfamerazine sodium salt |
B3430-50000 |
ApexBio |
50 g |
EUR 110 |
Description: Sulfamerazine Sodium is a sulfonamide antibacterial. |
GSK1349572 sodiuM salt |
B5856-10 |
ApexBio |
10 mg |
EUR 316 |
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor. |
GSK1349572 sodiuM salt |
B5856-100 |
ApexBio |
100 mg |
EUR 1210 |
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor. |
GSK1349572 sodiuM salt |
B5856-5 |
ApexBio |
5 mg |
EUR 241 |
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor. |
GSK1349572 sodiuM salt |
B5856-50 |
ApexBio |
50 mg |
EUR 728 |
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor. |
Resazurin sodium salt |
B6098-1000 |
ApexBio |
1 g |
EUR 84 |
Description: The non-fluorescent resazurin has been used as a fluorogenic oxidation-reduction indicator in various cells by flow cytometry, fluorescence microscopy and high-throughput screening. Its red-fluorescent product, resorufin, has absorption/emission maxima ~575/585 nm. |
Resazurin sodium salt |
B6098-5000 |
ApexBio |
5 g |
EUR 166 |
Description: The non-fluorescent resazurin has been used as a fluorogenic oxidation-reduction indicator in various cells by flow cytometry, fluorescence microscopy and high-throughput screening. Its red-fluorescent product, resorufin, has absorption/emission maxima ~575/585 nm. |
Dantrolene, sodium salt |
B6329-100 |
ApexBio |
100 mg |
EUR 132 |
Dantrolene, sodium salt |
B6329-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 108 |
Entacapone sodium salt |
B1090-10 |
ApexBio |
10 mg |
EUR 139 |
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds. |
Entacapone sodium salt |
B1090-100 |
ApexBio |
100 mg |
EUR 321 |
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds. |
Entacapone sodium salt |
B1090-50 |
ApexBio |
50 mg |
EUR 231 |
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds. |
Adapalene sodium salt |
B1277-100 |
ApexBio |
100 mg |
EUR 142 |
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR). |
Adapalene sodium salt |
B1277-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 108 |
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR). |
Adapalene sodium salt |
B1277-50 |
ApexBio |
50 mg |
EUR 108 |
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR). |
Novobiocin Sodium Salt |
B1526-1G |
Biovision |
|
EUR 109 |
Novobiocin Sodium Salt |
B1526-5G |
Biovision |
|
EUR 240 |
Cefazolin Sodium Salt |
B1530-1G |
Biovision |
|
EUR 142 |
Cefazolin Sodium Salt |
B1530-5G |
Biovision |
|
EUR 359 |
GSK2190915 sodium salt |
B4905-10 |
ApexBio |
10 mg |
EUR 429 |
GSK2190915 sodium salt |
B4905-5 |
ApexBio |
5 mg |
EUR 277 |
GSK2190915 sodium salt |
B4905-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 380 |
GSK2190915 sodium salt |
B4905-50 |
ApexBio |
50 mg |
EUR 1549 |
Ischemin sodium salt |
B4917-10 |
ApexBio |
10 mg |
EUR 268 |
Ischemin sodium salt |
B4917-50 |
ApexBio |
50 mg |
EUR 973 |
Proglumide sodium salt |
B5121-100 |
ApexBio |
100 mg |
EUR 139 |
Proglumide sodium salt |
B5121-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 150 |
(±)-Cloprostenol sodium salt |
B7004-1 |
ApexBio |
1 mg |
EUR 112 |
(±)-Cloprostenol sodium salt |
B7004-10 |
ApexBio |
10 mg |
EUR 363 |
(±)-Cloprostenol sodium salt |
B7004-5 |
ApexBio |
5 mg |
EUR 300 |
HEPES Sodium salt |
B7303-250000 |
ApexBio |
250 g |
EUR 286 |
CHPG Sodium salt |
B7475-10 |
ApexBio |
10 mg |
EUR 253 |
CHPG Sodium salt |
B7475-50 |
ApexBio |
50 mg |
EUR 902 |
Nigericin sodium salt |
B7644-10 |
ApexBio |
10 mg |
EUR 131 |
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane. |
Nigericin sodium salt |
B7644-25 |
ApexBio |
25 mg |
EUR 212 |
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane. |
Nigericin sodium salt |
B7644-5 |
ApexBio |
5 mg |
EUR 102 |
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane. |